Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Wednesday, shares of Celldex Therapeutics, Inc. ( CLDX - Get Report) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $13.24 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 41.8. A bullish investor could look at CLDX's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CLDX shares: Looking at the chart above, CLDX's low point in its 52 week range is $11.93 per share, with $32.82 as the 52 week high point — that compares with a last trade of $13.30. According to the ETF Finder at ETF Channel, CLDX makes up 1.88% of the First Trust NYSE Arca Biotechnology Index Fund ETF ( FBT) which is trading lower by about 0.5% on the day Wednesday.
More from Stocks
Splunk Shares Higher as J.P. Morgan Upgrades Software Firm to Overweight
Analyst Mark Murphy has been bullish on Splunk's fundamentals for at least three quarters, but concern about valuation kept the firm neutral. After a cash-flow guide-down, the `Street consensus [is] largely derisked.'
Cracker Barrel Shares Climb on Earnings Beat, Positive Outlook
Same-restaurant sales rose 3.8% in the quarter, and expectations for fiscal 2020 are for growth of 2% to 3%.
Burlington and TJX Shares Higher After Analyst Upgrade; Other Retailers Lower
While tariffs have hit traditional retailers hard, they have provided a big opportunity for Burlington, which has seen market-share gains as shoppers seek out less expensive alternatives, according to UBS.